SILO PHARMA, INC. Preferred Stock Convertible Shares Issuable
SILO PHARMA, INC. (SILO) had Preferred Stock Convertible Shares Issuable of 4.28 thousand shares as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Preferred Stock, Number of Shares, Par Value and Other Disclosure › Features of Convertible Preferred Stock
us-gaap:PreferredStockConvertibleSharesIssuable · last filed 2023-11-13
- 2023-09-30: Preferred Stock Convertible Shares Issuable 4.28K shares.
- 2023-06-30: Preferred Stock Convertible Shares Issuable 4.28K shares.
- 2021-02-09: Preferred Stock Convertible Shares Issuable 4.28K shares.
| Period end | Preferred Stock Convertible Shares Issuable |
|---|---|
| 2023-09-30 | 4.28K shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 4.28K shares 10-Q · filed 2023-08-11 |
| 2021-02-09 | 4.28K shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |